Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers

被引:7
|
作者
Walker, Melanie [1 ,4 ]
French, Simon D. [4 ,5 ]
Doiron, R. Christopher [3 ]
Brennan, Kelly [1 ]
Feldman-Stewart, Deb [1 ,2 ]
Siemens, D. Robert [2 ,3 ]
Mackillop, William J. [1 ,2 ,4 ]
Booth, Christopher M. [1 ,2 ,4 ]
机构
[1] Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, 10 Stuart St, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Oncol, Kingston, ON, Canada
[3] Queens Univ, Dept Urol, Kingston, ON, Canada
[4] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
[5] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada
关键词
Bladder cancer; Radiotherapy; Cystectomy; Knowledge translation; Quality of care; CLINICAL-PRACTICE; GUIDELINES; BEHAVIOR;
D O I
10.1016/j.radonc.2017.08.036
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To understand barriers and enablers to use of curative-intent radiotherapy (RT) for muscle invasive bladder cancer using the Theoretical Domains Framework (TDF). Methods: Canadian urologists, radiation oncologists (ROs) and medical oncologists (MOs) participated in a web-based survey to assess barriers and enablers to use of RT. Survey questions were thematically mapped to TDF domains. Logistic regression was used to identify TDF domains associated with high referral/use of RT. Results: 64 urologists, 29 ROs and 26 MOs participated. Participants reported comparable survival at five years with cystectomy (51%) and RT with concurrent chemotherapy (50%). Despite this, participants reported low RT referral treatment rates: Urologists referred a median of 2/10 patients to RO; ROs treated a median of 5/10 patients referred; and MOs referred a median of 2/8 patients not referred to RO by urology. Among urologists, the TDF domains 'beliefs about consequences' (OR = 8.1, 95% CI 1.5-44.9), 'social and professional role' (OR = 11.2, 95% CI 23-53.6) and 'environmental context and resources' (OR = 5.9, 95% CI 1.5-23.3) were associated with higher rates of RO referral. Conclusions: We have identified factors associated with referral for RT among patients with bladder cancer. These factors should be addressed as part of a concerted effort to increase utilization of RT. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:351 / 356
页数:6
相关论文
共 50 条
  • [1] Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers
    Walker, M.
    Doiron, R. C.
    French, S. D.
    Feldman-Stewart, D.
    Siemens, D. R.
    Mackillop, W. J.
    Booth, C. M.
    CLINICAL ONCOLOGY, 2017, 29 (12) : 818 - 826
  • [2] Bladder-Sparing Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer
    Ericson, Kyle J.
    Murthy, Prithvi B.
    Bryk, Darren J.
    Ramkumar, Rathika R.
    Broughman, James R.
    Khanna, Abhinav
    Mian, Omar Y.
    Campbell, Steven C.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (12) : 697 - 707
  • [3] Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
    Tholomier, Come
    Souhami, Luis
    Kassouf, Wassim
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2920 - 2937
  • [4] Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer
    Ben -David, Reuben
    Galsky, Matthew D.
    Sfakianos, John P.
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (07) : 686 - 697
  • [5] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [6] Bladder-sparing treatment options in localized muscle-invasive bladder cancer
    Nason, Gregory J.
    Ajib, Khaled
    Tan, Guan H.
    Kulkarni, Girish S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (03) : 179 - 188
  • [7] Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study
    Verschoor, Noortje
    Heemsbergen, Wilma D.
    Boormans, Joost L.
    Franckena, Martine
    ACTA ONCOLOGICA, 2022, 61 (08) : 1019 - 1025
  • [8] Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer
    de Angelis, Mario
    Basile, Giuseppe
    Scornajenghi, Carlo Maria
    Asero, Vincenzo
    Del Giudice, Francesco
    Moschini, Marco
    CURRENT OPINION IN UROLOGY, 2023, 33 (05) : 354 - 359
  • [9] Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future
    Koga, Fumitaka
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (11) : 1127 - 1139
  • [10] Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer
    Molitoris, Jason K.
    Simone, Charles B., II
    JAMA SURGERY, 2019, 154 (02) : 185 - 186